Twist Bioscience Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $65
Twist Bioscience | 10-Q: Quarterly report
Express News | Scorpion Capital (@ScorpionFund) Posts On X "We Remain Short $TWST Twist Bioscience With Strong Conviction That It Is a Zero. Detailed Thoughts on Monday. We're Doing a Fresh, Intensive Round of Research Which We May Publish as a Follow up to Our Nov...
Twist Bioscience: A Strong Buy Amid Temporary Setback and Promising Fiscal Year 2024 Outlook
Express News | Scorpion Capital - We Remain Short Twist Bioscience - X Post
Express News | Twist Bioscience Corp : Evercore ISI Raises Target Price to $52 From $50
Sector Update: Health Care Stocks Decline Premarket Friday
Sector Update: Health Care
Express News | Twist Bioscience Shares Are Trading Lower. The Company Reported Q3 Financial Results
Express News | Twist Bioscience Q3 2024 Adj. EPS $(0.70) Beats $(0.77) Estimate, Sales $81.464M Beat $77.404M Estimate
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Posts Q3 Revenue $81.5M, Vs. Street Est of $77.4M
Twist Bioscience Raises 4Q View To Rev $82M-$83M >TWST
Express News | Twist Bioscience Corp Sees Q4 Total Revenue of Approximately $82 Mln to $83 Mln
Express News | Twist Bioscience Q3 Orders USD 85.3 Million
Express News | Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
Express News | Twist Bioscience Q3 Revenue USD 81.464 Million Vs. IBES Estimate USD 77.4 Million
Express News | Twist Bioscience Outlook FY Revenue USD 310-311 Million
Express News | Twist Bioscience Q3 Operating Income USD -88.922 Million Vs. IBES Estimate USD -46.4 Million
Express News | Twist Bioscience Outlook FY Gross Margin 42%